The content discusses an enterprise taxonomy that includes areas such as AI, operations, analytics, workflow, digital health, business, and technology. It mentions node settings for excluding information from the Accelerate RSS feed.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
